ADMA logo

ADMA Biologics (ADMA) Cash from investing

annual CFI:

-$8.57M-$3.59M(-72.15%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ADMA annual cash flow from investing activities is -$8.57 million, with the most recent change of -$3.59 million (-72.15%) on December 31, 2024.
  • During the last 3 years, ADMA annual CFI has risen by +$4.94 million (+36.53%).
  • ADMA annual CFI is now -156.36% below its all-time high of $15.21 million, reached on December 31, 2017.

Performance

ADMA Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADMAcash flow metrics

quarterly CFI:

-$4.72M-$1.97M(-71.64%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADMA quarterly cash flow from investing activities is -$4.72 million, with the most recent change of -$1.97 million (-71.64%) on March 31, 2025.
  • Over the past year, ADMA quarterly CFI has dropped by -$2.36 million (-99.83%).
  • ADMA quarterly CFI is now -137.31% below its all-time high of $12.65 million, reached on June 30, 2017.

Performance

ADMA quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADMAcash flow metrics

TTM CFI:

-$10.93M-$2.36M(-27.50%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADMA TTM cash flow from investing activities is -$10.93 million, with the most recent change of -$2.36 million (-27.50%) on March 31, 2025.
  • Over the past year, ADMA TTM CFI has dropped by -$5.54 million (-102.54%).
  • ADMA TTM CFI is now -146.21% below its all-time high of $23.66 million, reached on June 30, 2017.

Performance

ADMA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADMAcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ADMA Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-72.2%-99.8%-102.5%
3 y3 years+36.5%-66.1%+20.7%
5 y5 years-125.0%-127.7%-89.3%

ADMA Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-72.2%+38.4%-523.5%at low-119.5%+21.4%
5 y5-year-125.0%+38.4%-523.5%at low-119.5%+21.4%
alltimeall time-156.4%+38.4%-137.3%+45.2%-146.2%+21.4%

ADMA Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$4.72M(+71.6%)
-$10.93M(+27.5%)
Dec 2024
-$8.57M(+72.2%)
-$2.75M(+150.5%)
-$8.57M(+18.6%)
Sep 2024
-
-$1.10M(-53.6%)
-$7.23M(+4.9%)
Jun 2024
-
-$2.37M(+0.1%)
-$6.89M(+27.7%)
Mar 2024
-
-$2.36M(+67.9%)
-$5.40M(+8.4%)
Dec 2023
-$4.98M(-64.2%)
-$1.41M(+85.9%)
-$4.98M(-32.0%)
Sep 2023
-
-$757.00K(-13.2%)
-$7.32M(-26.4%)
Jun 2023
-
-$872.00K(-55.2%)
-$9.95M(-23.6%)
Mar 2023
-
-$1.95M(-48.1%)
-$13.01M(-6.4%)
Dec 2022
-$13.91M(+3.0%)
-$3.75M(+10.9%)
-$13.91M(+0.5%)
Sep 2022
-
-$3.38M(-14.2%)
-$13.84M(+4.5%)
Jun 2022
-
-$3.94M(+38.6%)
-$13.25M(-3.9%)
Mar 2022
-
-$2.84M(-22.7%)
-$13.78M(+2.0%)
Dec 2021
-$13.51M(+6.2%)
-$3.68M(+31.8%)
-$13.51M(+0.6%)
Sep 2021
-
-$2.79M(-37.7%)
-$13.43M(-0.7%)
Jun 2021
-
-$4.48M(+74.1%)
-$13.53M(+2.3%)
Mar 2021
-
-$2.57M(-28.5%)
-$13.22M(+3.9%)
Dec 2020
-$12.72M(+233.8%)
-$3.60M(+24.7%)
-$12.72M(+18.7%)
Sep 2020
-
-$2.89M(-30.8%)
-$10.72M(+9.3%)
Jun 2020
-
-$4.17M(+101.1%)
-$9.81M(+69.8%)
Mar 2020
-
-$2.07M(+30.0%)
-$5.77M(+51.5%)
Dec 2019
-$3.81M(+81.9%)
-$1.59M(-19.1%)
-$3.81M(+25.5%)
Sep 2019
-
-$1.97M(+1358.5%)
-$3.04M(+134.5%)
Jun 2019
-
-$135.20K(+22.4%)
-$1.29M(-21.8%)
Mar 2019
-
-$110.50K(-86.5%)
-$1.66M(-20.9%)
Dec 2018
-$2.10M(-113.8%)
-$819.00K(+255.8%)
-$2.10M(-36.2%)
Sep 2018
-
-$230.20K(-53.7%)
-$3.29M(-9.4%)
Jun 2018
-
-$497.10K(-9.5%)
-$3.63M(-138.1%)
Mar 2018
-
-$549.20K(-72.7%)
$9.52M(-37.4%)
Dec 2017
$15.21M
-$2.01M(+252.7%)
$15.21M(-33.4%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$569.90K(-104.5%)
$22.85M(-3.4%)
Jun 2017
-
$12.65M(+146.1%)
$23.66M(+889.8%)
Mar 2017
-
$5.14M(-8.6%)
$2.39M(+164.2%)
Dec 2016
$904.60K(-151.9%)
$5.63M(+2255.2%)
$904.60K(+33.3%)
Sep 2016
-
$238.90K(-102.8%)
$678.80K(-85.2%)
Jun 2016
-
-$8.62M(-335.7%)
$4.60M(-47.7%)
Mar 2016
-
$3.66M(-32.3%)
$8.79M(-604.6%)
Dec 2015
-$1.74M(-56.9%)
$5.40M(+29.9%)
-$1.74M(-71.1%)
Sep 2015
-
$4.16M(-193.9%)
-$6.03M(-48.0%)
Jun 2015
-
-$4.43M(-35.6%)
-$11.59M(+0.5%)
Mar 2015
-
-$6.87M(-718.9%)
-$11.53M(+185.5%)
Dec 2014
-$4.04M(+29.0%)
$1.11M(-179.2%)
-$4.04M(-50.1%)
Sep 2014
-
-$1.40M(-67.9%)
-$8.09M(+20.7%)
Jun 2014
-
-$4.37M(-804.5%)
-$6.71M(+174.2%)
Mar 2014
-
$620.20K(-121.1%)
-$2.45M(-21.9%)
Dec 2013
-$3.13M(+2534.0%)
-$2.94M(>+9900.0%)
-$3.13M(+1282.7%)
Sep 2013
-
-$16.40K(-84.9%)
-$226.50K(-4.6%)
Jun 2013
-
-$108.70K(+64.4%)
-$237.50K(+28.4%)
Mar 2013
-
-$66.10K(+87.3%)
-$185.00K(+55.6%)
Dec 2012
-$118.90K(<-9900.0%)
-$35.30K(+28.8%)
-$118.90K(+42.2%)
Sep 2012
-
-$27.40K(-51.2%)
-$83.60K(+48.8%)
Jun 2012
-
-$56.20K(<-9900.0%)
-$56.20K(<-9900.0%)
Mar 2012
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2011
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2010
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00
$0.00
Jun 2010
$0.00
-
-

FAQ

  • What is ADMA Biologics annual cash flow from investing activities?
  • What is the all time high annual CFI for ADMA Biologics?
  • What is ADMA Biologics annual CFI year-on-year change?
  • What is ADMA Biologics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ADMA Biologics?
  • What is ADMA Biologics quarterly CFI year-on-year change?
  • What is ADMA Biologics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ADMA Biologics?
  • What is ADMA Biologics TTM CFI year-on-year change?

What is ADMA Biologics annual cash flow from investing activities?

The current annual CFI of ADMA is -$8.57M

What is the all time high annual CFI for ADMA Biologics?

ADMA Biologics all-time high annual cash flow from investing activities is $15.21M

What is ADMA Biologics annual CFI year-on-year change?

Over the past year, ADMA annual cash flow from investing activities has changed by -$3.59M (-72.15%)

What is ADMA Biologics quarterly cash flow from investing activities?

The current quarterly CFI of ADMA is -$4.72M

What is the all time high quarterly CFI for ADMA Biologics?

ADMA Biologics all-time high quarterly cash flow from investing activities is $12.65M

What is ADMA Biologics quarterly CFI year-on-year change?

Over the past year, ADMA quarterly cash flow from investing activities has changed by -$2.36M (-99.83%)

What is ADMA Biologics TTM cash flow from investing activities?

The current TTM CFI of ADMA is -$10.93M

What is the all time high TTM CFI for ADMA Biologics?

ADMA Biologics all-time high TTM cash flow from investing activities is $23.66M

What is ADMA Biologics TTM CFI year-on-year change?

Over the past year, ADMA TTM cash flow from investing activities has changed by -$5.54M (-102.54%)
On this page